Insider trade

Rocket Pharmaceuticals (RCKT)See Remarks sold ~$64K

Jonathan David Schwartz, See Remarks at Rocket Pharmaceuticals, sold ~$64K of Rocket Pharmaceuticals shares.

~$64K
Approx. value · 2,754 sh @ $23.35: 170K
Holds after · shares reported

Traded: May 17, 2024
Filed: Feb 27, 2025

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Rocket Pharmaceuticals

OQRO holds no insider, Congress, fund or contract record for Rocket Pharmaceuticals dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RCKT page.

Other recent filings by Jonathan David Schwartz, See Remarks

The full history of Jonathan David Schwartz, See Remarks is on the profile page.

How this filing works

Other disclosures at Rocket Pharmaceuticals

Everything OQRO holds on this company is on its RCKT page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data